tiprankstipranks
Axsome Therapeutics Inc (AXSM)
NASDAQ:AXSM
US Market

Axsome Therapeutics (AXSM) Income Statement

Compare
2,093 Followers

Axsome Therapeutics Income Statement

Last quarter (Q3 2024), Axsome Therapeutics's total revenue was $104.76M, an increase of 81.27% from the same quarter last year. In Q3, Axsome Therapeutics's net income was $-64.60M. See Axsome Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 270.60M$ 50.04M$ 0.00$ 0.00$ 0.00
Gross Profit
$ 244.53M$ 44.84M$ -1.16M$ -77.72K$ -37.33K
Operating Expenses
$ 476.36M$ 221.34M$ 124.71M$ 99.09M$ 67.11M
Depreciation and Amortization
$ 6.83M$ 5.56M$ 1.16M$ 77.72K$ 37.33K
EBITDA
$ -224.99M$ -174.23M$ -123.55M$ -99.06M$ -67.21M
Operating Income
$ -231.82M$ -176.50M$ -124.71M$ -99.14M$ -67.25M
Other Income/Expenses
$ -6.45M$ -7.33M$ -5.70M$ -3.81M$ -1.24M
Pretax Income
$ -238.28M$ -187.13M$ -130.40M$ -102.90M$ -68.35M
Net Income
$ -239.24M$ -197.77M$ -134.94M$ -105.39M$ -69.69M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -5.27$ -4.86$ -3.59$ -2.83$ -2.05
Diluted EPS
$ -5.27$ -4.86$ -3.59$ -2.83$ -2.05
Weighted Average Shares Outstanding
45.43M 40.66M 37.62M 37.21M 34.02M
Weighted Average Shares Outstanding (Diluted)
45.43M 40.66M 37.62M 37.21M 34.02M
Currency in USD

Axsome Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis